RPAM
CLLS

Rhenman & Partners Asset Management’s Cellectis CLLS Stock Holding History

Rhenman & Partners Asset Management’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-144,604
Closed -$2.67M – 87
2020
Q3 		$2.67M Hold
144,604
– – 0.24% 74
2020
Q2 		$2.57M Hold
144,604
– – 0.28% 78
2020
Q1 		$1.33M Hold
144,604
– – 0.19% 78
2019
Q4 		$2.48M Buy
+144,604
New +$1.93M 0.27% 78

Other funds holding CLLS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

Rhenman & Partners Asset Management's CLLS Position: Q4 2020 in Review

Rhenman & Partners Asset Management sold out of Cellectis (CLLS) in Q4 2020, closing a stake of 144,604 shares — an estimated $2.67M sold.

Rhenman & Partners Asset Management first reported a position in CLLS in Q4 2019 and held it in 4 quarters. The position peaked at $2.67M in Q3 2020. 90 funds tracked by Wall St. Rank hold CLLS as of Q4 2020.

  • Rhenman & Partners Asset Management reported no remaining Cellectis position as of Q4 2020 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 144,604 Cellectis shares in Q4 2020, an estimated $2.67M.
  • Rhenman & Partners Asset Management first reported a position in Cellectis in Q4 2019 and held it in 4 quarters.
  • Rhenman & Partners Asset Management's Cellectis position peaked at $2.67M in Q3 2020.
  • 90 funds tracked by Wall St. Rank held Cellectis as of Q4 2020.

Based on Rhenman & Partners Asset Management's 13F filing for Q4 2020, filed 19 Jan 2021.